2749 E. PARLEYS WAY, SALT LAKE CITY, UT
Appoints Scott Gleason Chief Financial Officer
Reports Second Quarter 2026 Financial Results
Election of Directors - Kim Kamdar and Sandra Lawrence Appointed
Announces Board Transition
Annual Report to Security Holders
Reports Fourth Quarter 2025 Financial Results
Investor Presentation
Landmark Study Finds Blood Test Reduces Earliest Preterm Births and Newborn Complications
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload